IPOMarket.in — India IPO tracker

Goldline Pharmaceutical IPO

UPCOMINGSME
Price Band
₹41 – ₹43
Lot Size
3000
Lot Value
₹1,29,000
Open Date
12 May 2026
Close Date
14 May 2026
Min Investment
₹1,29,000

IPO Timeline

1

Issue Opens

12 May 2026 · Tue

2

Issue Closes

14 May 2026 · Thu

3

Allotment

15 May 2026 · Fri

4

Listing

19 May 2026 · Tue

IPOMarket Analysis

IPOMarket Analysis

ANALYSIS PENDING

Rating will be available once IPO opens for subscription.

This is algorithmic analysis, not investment advice. Always read the DRHP before investing.

IPO Details

RegistrarBigshare Services Pvt.Ltd.
ExchangeBSE SME
ISIN
Face Value₹10
Issue Size₹12.00 Cr
Fresh Issue
OFS Size
Lead Managers

About Goldline Pharmaceutical

No information available yet.

3-Year Financial Summary

Financial data not available yet.

GMP Trend

Quick Profit Calculator

Pre-filled: Issue Price = ₹43, Lot Size = 3000 shares

Number of Lots

Investment (1 lot):₹1,29,000
LotsInvestment
1₹1,29,000
2₹2,58,000
3₹3,87,000
5₹6,45,000
10₹12,90,000

Estimated profit based on GMP. Actual listing price may vary.

Subscription Status

Subscription data will appear once bidding begins.

Peer Comparison

CompanyListedListing Gain
Amba Auto Sales & Services05 May 2026
Adisoft Technologies30 Apr 2026
Mehul Telecom24 Apr 2026

Related IPOs

Documents

Documents not available yet

Frequently Asked Questions

When is the Goldline Pharmaceutical IPO opening?

The Goldline Pharmaceutical IPO opens on 12 May 2026 and closes on 14 May 2026. Check this page for the latest updates as we refresh every 30 minutes.

What is the price band of the Goldline Pharmaceutical IPO?

The price band for the Goldline Pharmaceutical IPO is ₹41 to ₹43. The final price is announced after the book-building process and is confirmed before listing.

What is the lot size and minimum investment for the Goldline Pharmaceutical IPO?

The minimum lot size is 3000 shares with a minimum investment of ₹1,29,000. Retail investors can apply for up to the retail limit defined by SEBI.

What is the GMP of Goldline Pharmaceutical IPO today?

Grey Market Premium data for Goldline Pharmaceutical is not available yet. It typically starts appearing a few days before the IPO opens.

When will the Goldline Pharmaceutical IPO list on NSE and BSE?

The Goldline Pharmaceutical IPO is expected to list on 19 May 2026 on BSE SME. Actual listing day trading begins at the start of the normal market session.

How can I check the Goldline Pharmaceutical IPO allotment status?

The registrar for this IPO is Bigshare Services Pvt.Ltd.. You can check your allotment status on the registrar's portal using your PAN, application number, or DP ID. We link to the registrar directly on our allotment page after the allotment date.

Is the Goldline Pharmaceutical IPO a mainboard or SME issue?

Goldline Pharmaceutical is a SME IPO that will list on the NSE Emerge or BSE SME platform. SME IPOs require a minimum application value of one lakh rupees.

How do I apply for the Goldline Pharmaceutical IPO?

You can apply for the Goldline Pharmaceutical IPO through any SEBI-registered broker such as Zerodha, Upstox, or Angel One using UPI or ASBA. Use the Apply Now buttons on this page to go directly to the broker.

Should I subscribe to Goldline Pharmaceutical IPO?

Based on our algorithmic analysis, Goldline Pharmaceutical IPO is rated UNRATED with low confidence. Rating will be available once subscription and GMP data is collected. This is not investment advice — please read the DRHP and consult a financial advisor before investing.

Related Articles

IPO Tools

Financial Disclaimer: The information on this page is for educational purposes only and does not constitute investment advice. IPO investments are subject to market risks. Grey Market Premium (GMP) figures are unofficial and not endorsed by SEBI, NSE, or BSE. Past performance is not indicative of future returns. Please read the RHP and consult a SEBI-registered advisor before investing.